FBXO21 and acute myeloid leukemia: Protein expression analysis in mononuclear cells from peripheral blood (PB) of nine AML patients with French-American-British classifications ranging from M0–M4 showed an increase in the levels of FBXO21 compared to two healthy human total BM samples (Fig. 1C).